Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
17.37
↓ 74% below average
Average (9y)
66.40
Historical baseline
Range
High:236.09
Low:0.40
CAGR
+0.8%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 17.37 | +156.8% |
| 2023 | 6.76 | -36.5% |
| 2022 | 10.64 | -89.2% |
| 2021 | 98.93 | -58.1% |
| 2020 | 236.09 | +99.9% |
| 2019 | 118.13 | +2.7% |
| 2018 | 115.05 | +159.0% |
| 2017 | 44.41 | +10872.3% |
| 2016 | 0.40 | -97.5% |
| 2015 | 16.17 | - |